论文部分内容阅读
目的：评价斯普林在放射治疗Ⅲ期非小细胞肺癌中的作用。方法：４０ 例不能手术的Ⅲ期非小细胞肺癌被随机分两组，２０ 例单纯放疗（ 对照组） ，２０ 例放疗联合斯普林注射，从放疗前１ 周至放疗后１ 周，每日肌注或静点４ ～１０ｍｌ，５ 次 周。两组放疗方式剂量相同。每次１７ ～２０ Ｇｙ ，每周５ 次，总剂量６０ ～７０ Ｇｙ 。结果：综合组总有效率７０ ％ ，对照组５５ ％ 。综合组治疗后的 Ｗ Ｂ Ｃ、 Ｎ Ｋ 活性、 Ｔ３ 、 Ｔ４ 、 Ｔ４ Ｔ８ 等值均优于对照组，差别有统计学意义。结论：放疗合并斯普林能提高Ⅲ期非小细胞肺癌疗效，斯普林还有保护血象、增强免疫、改善病人一般状况的作用。
Objective: To evaluate the role of spring in radiotherapy for stage III non-small cell lung cancer. METHODS: Forty patients with stage III non-small cell lung cancer that could not be operated on were randomized into two groups: 20 patients with radiotherapy alone (control group) and 20 patients with radiotherapy combined with spring injection, from 1 week before radiotherapy to 1 week after radiotherapy, daily muscle Note or static 4 ~ 10ml, 5 times per week. The two groups had the same dose of radiation therapy. Each time 1 7 2 0 Gy, 5 times a week, the total dose of 60 ~ 70 Gy. Results: The total efficiency of the integrated group was 70%, and that of the control group was 55%. After treatment, W B C, N K activity, T3, T4, and T4 T8 were all significantly higher in the comprehensive group than in the control group. The difference was statistically significant. Conclusion: Radiotherapy combined with spring can improve the curative effect of stage III non-small cell lung cancer. Spring also has the effect of protecting blood, enhancing immunity and improving the general condition of patients.